Successful combination therapy for patients with platinum-resistant ovarian cancer

被引：0
|
作者：
不详
机构：
来源：
EXPERT REVIEW OF ANTICANCER THERAPY | 2008年 / 8卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：7 / 7
页数：1
相关论文
共 50 条
  • [1] Paclitaxel in platinum-resistant ovarian cancer patients
    Ezcurdia, L
    Jovtis, SL
    Mickiewicz, E
    Temperley, G
    Rondinon, M
    Blajman, C
    Coppola, FS
    Lewi, D
    Cazap, E
    Breier, S
    Fasce, H
    Fein, L
    Polera, J
    Triguboff, E
    Uranga, G
    Pasccon, G
    Luchina, AM
    Martinez, CA
    Politi, PM
    Rubio, G
    Alvarez, AM
    SEMINARS IN ONCOLOGY, 1997, 24 (05) : 53 - 56
  • [2] Emerging Role for Bevacizumab in Combination With Chemotherapy for Patients With Platinum-Resistant Ovarian Cancer
    Liu, Joyce F.
    Cannistra, Stephen A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (13) : 1287 - 1289
  • [3] Current aspects in the therapy of platinum-resistant ovarian cancer
    Sehouli, J.
    Pirvulescu, C.
    Mustea, A.
    Koensgen, D.
    Lichtenegger, W.
    Oskay-Oezcelik, G.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2007, 67 (08) : 823 - 830
  • [4] Management of platinum-resistant ovarian cancer with the combination of pemetrexed and gemcitabine
    Gasent Blesa, Joan Manel
    Alberola Candel, Vicente
    Provencio Pulla, Mariano
    Esteban Gonzalez, Emilio
    Martin Algarra, Salvador
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (01): : 35 - 40
  • [5] Management of platinum-resistant ovarian cancer with the combination of pemetrexed and gemcitabine
    Joan Manel Gasent Blesa
    Vicente Alberola Candel
    Mariano Provencio Pulla
    Emilio Esteban González
    Salvador Martín Algarra
    Clinical and Translational Oncology, 2009, 11 : 35 - 40
  • [6] Platinum retreatment of platinum-resistant ovarian cancer after nonplatinum therapy
    Leitao, MM
    Hummer, A
    Dizon, DS
    Aghajanian, C
    Hensley, M
    Sabbatini, P
    Venkatraman, E
    Spriggs, DR
    GYNECOLOGIC ONCOLOGY, 2003, 91 (01) : 123 - 129
  • [7] Genetic features of platinum-resistant ovarian cancer patients
    V.G.Dubinina
    A.I.Rybin
    M.A.Lysenko
    中国现代医学杂志, 2014, 24 (15) : 1 - 4
  • [8] Treosulfan in platinum-resistant ovarian cancer
    Olesen, Katrine Dam
    Larsen, Anja Tolstrup Raedkjaer
    Jensen, Lars Henrik
    Steffensen, Karina Dahl
    Sondergaard, Stine Rauff
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (07) : 1045 - 1051
  • [9] Immunotherapy for platinum-resistant ovarian cancer
    Bogani, Giorgio
    Lopez, Salvatore
    Mantiero, Mara
    Ducceschi, Monika
    Bosio, Sara
    Ruisi, Simona
    Sarpietro, Giuseppe
    Guerrisi, Rocco
    Brusadelli, Claudia
    Dell'Acqua, Andrea
    Di Donato, Violante
    Raspagliesi, Francesco
    GYNECOLOGIC ONCOLOGY, 2020, 158 (02) : 484 - 488
  • [10] Bevacizumab in patients with advanced platinum-resistant ovarian cancer.
    Cannistra, S. A.
    Matulonis, U.
    Penson, R.
    Wenham, R.
    Armstrong, D.
    Burger, R. A.
    Mackey, H.
    Douglas, J.
    Hambleton, J.
    McGuire, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 257S - 257S
12345